As recent work has demonstrated the presence of VEGFR-1 in multiple colon cancer cell lines and in both primary and metastatic tumour samples (Fan et al, 2005), VEGFR-1 may be a relevant clinical target, not only for its expression in endothelial cells but also for its expression/function in tumour cells. The gene discussed is FLT1; the disease is neoplasm.